Manufacturers, Compounders Clash As FDA Prepares Final Offer On Office Compounding

Pharmaceutical manufacturers and compounders are in opposition over the US FDA’s plans to carve out a place for pharmacies that want to keep physicians’ offices stocked with small amounts of product. Who will the agency disappoint this time?